Skip to main content

Month: May 2021

AMD President and CEO Dr. Lisa Su to Keynote COMPUTEX 2021

“AMD Accelerating – The High-Performance Computing Ecosystem” keynote to highlight new leadership products and vision for the future of computing SANTA CLARA, Calif., May 20, 2021 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) today announced that AMD President and CEO Dr. Lisa Su will keynote COMPUTEX 2021, one of the leading global technology tradeshows focused on the theme of “Building Global Technology Ecosystems” in 2021. Dr. Su will present the AMD vision for the future of computing, including the growing adoption of AMD high-performance computing and graphics solutions in the keynote titled “AMD Accelerating – The High-Performance Computing Ecosystem.” The digital keynote will be livestreamed at 10:00 AM (GMT+8) on Tuesday, June 1 and can be accessed on the COMPUTEX 2021 Hybrid platform as well as AMD.com. Organized by the Taiwan...

Continue reading

Industry Veterans Launch NJ-Based RIA Talisman Wealth Advisors

The New RIA Has Selected LPL Financial as Custodian CHARLOTTE, N.C., May 20, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC today announced that financial advisors Jennifer Kirby and Frank Granizo launched their new RIA, Talisman Wealth Advisors, and selected LPL Financial as their custodian. The principals of Talisman most recently operated as The Granizo Kirby Group at Merrill Lynch and reported having served approximately $150 million in advisory assets*. Granizo is an industry veteran with more than 20 years of experience as a financial advisor. Kirby entered the business about eight years ago after more than a decade in fundraising and public relations, where she gained operational and financial management experience working with donors and wealthy individuals. The two teamed up in 2018 after discovering they shared similar views...

Continue reading

Vistin Pharma ASA: Minutes from the annual general meeting 2021

Oslo, Norway, 20 May 2021 Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the annual general meeting held on 20 May 2021. All matters were resolved as proposed in the call for the annual general meeting. For further information, please contact:Alexander KarlsenCFO+47 97 05 36 21alexander.karlsen@vistin.comThis information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.  AttachmentMinutes_from_AGM_2021_Vistin_Pharma_ASA

Continue reading

Six universities of applied sciences selected Innofactor as supplier for case management solution

Innofactor Plc insider information on May 20, 2021 at 15.50 Finnish time  Metropolia University of Applied Sciences Ltd, Turku University of Applied Sciences Ltd, Haaga-Helia University of Applied Sciences Ltd, Novia University of Applied Sciences, Arcada University of Applied Sciences Ltd and Finnish University of Applied Sciences and Arts Ltd have selected Innofactor in a joint public procurement competition as the supplier of a case management solution. The public procurement competition was divided into SaaS and On-Premise areas, and Innofactor was selected as the supplier for both of these. The procurement consists of the delivery of Innofactor’s Dynasty 10 system to these universities of applied sciences, support and maintenance services, specialist services, as well as integrations and migrations specific to each university of...

Continue reading

Amerant Mortgage Expands its Footprint and Capabilities With the Acquisition of Idaho-based First Mortgage Company

Acquisition Provides Direct Access to Fannie Mae, HUD/FHA, and Veterans Administration CORAL GABLES, Fla., May 20, 2021 (GLOBE NEWSWIRE) — Amerant Mortgage, LLC, a joint venture between Amerant Bank, the second largest community bank headquartered in Florida, and a team of highly specialized professionals in the residential mortgage arena, announced today that it had acquired Boise, Idaho-based First Mortgage Company, Inc (“First Mortgage”). With the acquisition, First Mortgage was re-branded as Amerant Mortgage and will retain all its existing employees. The office will be Amerant’s first outside of Florida “The First Mortgage team has nearly 35 years of experience serving their community’s needs, and we look forward to expanding our services into Idaho,” said Miguel Palacios, Chief Business Officer, Amerant Bank. “We are extremely...

Continue reading

North America Baby Bottle Market to Reach USD 356.7 Million by 2028; Increasing Demand for Sustainable Bottles to Stimulate Growth, Says Fortune Business Insights™

Top companies covered are Munchkin, Inc. (California, U.S.), PIGEON CORPORATION (Tokyo, Japan), Mayborn Group Limited (Benton Ln, U.K.), Babisil International Ltd. (Siu Lek Yuen, Hong Kong), Handi-Craft Company (Missouri, U.S.), Newell Brands Inc. (New York, U.S.), Koninklijke Philips N.V. (Amsterdam, Netherland), Comotomo Inc. (Sunnyvale, U.S.), Kiinde LLC (Melbourne, U.S.), Pacific baby Incorporated (Salt Lake City, U.S.), GoodBaby International Holdings Ltd. (Suzhou, China), and more players profiled in North America baby bottle market research report Pune, India, May 20, 2021 (GLOBE NEWSWIRE) — The North America baby bottle market size is expected to gain momentum by reaching USD 356.7 million by 2028 while exhibiting a CAGR of 3.6% between 2021 and 2028. This information is published by Fortune Business Insights™ in its latest...

Continue reading

Gainwell’s HMS Donates $20,000 to Girlstart to Support STEM Camps for Girls

IRVING, Texas, May 20, 2021 (GLOBE NEWSWIRE) — For the second year in a row, HMS, a Gainwell Technologies Company, announced it has donated $20,000 to Girlstart, an organization that designs and implements innovative, high-quality STEM (science, technology, engineering, and math) education programs for young girls nationwide. Girlstart hosts programs throughout the year, including community STEM events, afterschool programs and their Girlstart Summer Camp each year. This year, HMS’ donation will help fund the 2021 Summer Camp program by providing high-quality science kits for campers to build Micro:bits. These pocket-sized computers with LED displays, microphones, speakers and sensors allow children to explore how hardware and software work together. All the materials and tools required will be shipped to campers unable to attend...

Continue reading

Everi and Caesars Palace to Install Jackpot Xpress

LAS VEGAS, May 20, 2021 (GLOBE NEWSWIRE) — Everi Holdings Inc. (NYSE: EVRI) (“Everi” or the “Company”), a premier provider of land-based and digital casino gaming content and products, financial technology, and loyalty solutions, today announced an agreement with Caesars Entertainment, Inc. (NASDAQ: CZR) (“Caesars”) to begin a Nevada field trial for Jackpot Xpress®, Everi’s jackpot management system, under guidelines issued by the Nevada Gaming Control Board. The trial will take place at the iconic Las Vegas Strip centerpiece, Caesars Palace. Upon final approval by the Nevada Gaming Control Board, Caesars will have the option to install Jackpot Xpress at all its Nevada properties. Caesars will also have the option to install Jackpot Xpress at all its owned and managed locations, pending further jurisdictional approvals. Jackpot...

Continue reading

Replimune Reports Fiscal Fourth Quarter and Year-Ended 2021 Financial Results and Provides Corporate Update

Added complete response as an independent primary endpoint in registration-directed CERPASS study in CSCC and held Type B meeting with FDA to discuss the IGNYTE study in anti-PD1 failed melanoma Dosed first patient with RP1 in the anti-PD1 failed NSCLC lung cancer cohort of the IGNYTE study Data update on lead programs to be provided during virtual investor event on June 3, 2021  Strengthened management team to prepare for potential commercial launch and enable further later stage development Ended fiscal year 2021 with approximately $476 million in Cash; Capitalized into second half of 2024 WOBURN, Mass., May 20, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing a series of oncolytic immuno-gene therapies derived from its Immulytic® platform, today announced financial results for...

Continue reading

PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting

Objective responses (tumor reduction) observed in 83% (5 of 6) of HPV16-positive relapsed or refractory checkpoint inhibitor naïve patients and 63% (5 of 8) of HPV16-positive relapsed or refractory advanced cancer patients who have also failed checkpoint inhibitor therapy FLORHAM PARK, N.J., May 20, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced publication of abstract #2501 by the American Society of Clinical Oncology (ASCO). The abstract summarizing interim data from the National Cancer Institute (NCI)-led phase 2 trial has been accepted for oral presentation at the 2021 ASCO Annual Meeting taking place June 4-8. The presentation, scheduled...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.